IDEXX Laboratories's Total Assets for the quarter that ended in Mar. 2024 was R$16,700 Mil.
Warning Sign:
If a company builds assets at 14.9% a year, faster than its revenue growth rate of 12.3% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, IDEXX Laboratories's average Total Assets Growth Rate was 9.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 13.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 14.90% per year.
During the past 10 years, the average Total Assets Growth Rate was 12.10% per year.
During the past 13 years, IDEXX Laboratories's highest 3-Year average Total Assets Growth Rate was 49.60%. The lowest was -1.20%. And the median was 9.30%.
The historical data trend for IDEXX Laboratories's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
IDEXX Laboratories's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (BSP:I1DX34) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
IDEXX Laboratories's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
IDEXX Laboratories Total Assets Related Terms
Thank you for viewing the detailed overview of IDEXX Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
IDEXX Laboratories (BSP:I1DX34) Business Description
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:I1DX34 has been successfully added to your 